Melissa Epperly - 23 Jan 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
Issuer symbol
ROIV
Transactions as of
23 Jan 2025
Transactions value $
-$2,018
Form type
4
Filing time
27 Jan 2025, 21:00:29 UTC
Previous filing
23 Oct 2024
Next filing
21 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +1,672 +4.4% $0 39,709 23 Jan 2025 Direct F1
transaction ROIV Common Shares Tax liability -$2,017 -180 -0.45% $11.21 39,529 23 Jan 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.